530317 — Godavari Drugs Cashflow Statement
0.000.00%
- IN₹689.72m
- IN₹1.25bn
- IN₹1.57bn
- 86
- 69
- 28
- 69
Annual cashflow statement for Godavari Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 63.6 | 102 | 116 | 108 | 138 |
Deferred Taxes | |||||
Non-Cash Items | -3.28 | -4.1 | -2.76 | -6.55 | -6.17 |
Other Non-Cash Items | |||||
Changes in Working Capital | 3.1 | -81.1 | 4.88 | 32 | 52 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 62.4 | 13.3 | 112 | 132 | 184 |
Capital Expenditures | -68.9 | -16.7 | -52.5 | -93 | -132 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 2.09 | 4.22 | 2.74 | 6.58 | -0.202 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -66.8 | -12.5 | -49.7 | -86.4 | -132 |
Financing Cash Flow Items | -28.1 | -31.9 | -29.1 | -39.4 | -48.7 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 3.37 | 1.34 | -56.2 | -37.7 | -56.5 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.993 | 2.12 | 6.38 | 8.08 | -4.62 |